Perry Moore

433 total citations
15 papers, 255 citations indexed

About

Perry Moore is a scholar working on Neurology, Pathology and Forensic Medicine and Cognitive Neuroscience. According to data from OpenAlex, Perry Moore has authored 15 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Pathology and Forensic Medicine and 4 papers in Cognitive Neuroscience. Recurrent topics in Perry Moore's work include Multiple Sclerosis Research Studies (5 papers), Epilepsy research and treatment (4 papers) and Autoimmune Neurological Disorders and Treatments (2 papers). Perry Moore is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Epilepsy research and treatment (4 papers) and Autoimmune Neurological Disorders and Treatments (2 papers). Perry Moore collaborates with scholars based in United Kingdom, France and Germany. Perry Moore's co-authors include Matthew A. Lambon Ralph, Grace E. Rice, Paul Hoffman, Helen Caswell, Kerry Mutch, Abigail Methley, Anu Jacob, Shahd Hamid, Liene Elsone and Mark Wardle and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Cerebral Cortex and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Perry Moore

13 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perry Moore United Kingdom 7 101 97 83 52 23 15 255
Banu Şatana Türkiye 13 98 1.0× 82 0.8× 46 0.6× 72 1.4× 9 0.4× 27 672
Ryota Nakamura Japan 9 61 0.6× 35 0.4× 79 1.0× 29 0.6× 17 0.7× 26 241
Silvana L. Costa United States 9 64 0.6× 190 2.0× 55 0.7× 37 0.7× 15 0.7× 24 296
Frederick Schon United Kingdom 5 145 1.4× 26 0.3× 47 0.6× 57 1.1× 9 0.4× 6 256
Aaron Tansy United States 7 401 4.0× 46 0.5× 31 0.4× 25 0.5× 14 0.6× 15 513
E. Donnemiller Austria 9 96 1.0× 61 0.6× 43 0.5× 55 1.1× 7 0.3× 20 305
Stefano Pensiero Italy 12 114 1.1× 63 0.6× 29 0.3× 15 0.3× 12 0.5× 41 519
Paulo Breno Noronha Liberalesso Brazil 11 51 0.5× 20 0.2× 51 0.6× 68 1.3× 30 1.3× 45 289
Ioannis N. Mavridis Greece 10 70 0.7× 17 0.2× 110 1.3× 26 0.5× 9 0.4× 50 285
R Khalil France 5 194 1.9× 59 0.6× 26 0.3× 25 0.5× 12 0.5× 11 322

Countries citing papers authored by Perry Moore

Since Specialization
Citations

This map shows the geographic impact of Perry Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Moore more than expected).

Fields of papers citing papers by Perry Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Moore. The network helps show where Perry Moore may publish in the future.

Co-authorship network of co-authors of Perry Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Perry Moore. A scholar is included among the top collaborators of Perry Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Moore. Perry Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bézenac, Christophe de, Ahmad Ali, Rajiv Mohanraj, et al.. (2025). Prospective neuroimaging and neuropsychological evaluation in adults with newly diagnosed focal epilepsy. Epilepsia. 66(8). 2864–2880.
2.
Fernández, Cristina, Kelly Davies, Sylviane Defres, et al.. (2021). Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis. BMJ Open. 11(7). e041808–e041808. 18 indexed citations
3.
Fisher, Peter, et al.. (2021). The Association Between Maladaptive Metacognitive Beliefs and Emotional Distress in People Living With Amyotrophic Lateral Sclerosis. Frontiers in Psychology. 12. 609068–609068. 3 indexed citations
4.
Moore, Perry, Martin Bunnage, Steven Kemp, Liam Dorris, & Gus A. Baker. (2021). Guidance on the Assessment of Performance Validity in Neuropsychological Assessments. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 2 indexed citations
5.
Bézenac, Christophe de, Marta García‐Fiñana, Gus A. Baker, et al.. (2019). Investigating imaging network markers of cognitive dysfunction and pharmacoresistance in newly diagnosed epilepsy: a protocol for an observational cohort study in the UK. BMJ Open. 9(10). e034347–e034347. 9 indexed citations
6.
Rice, Grace E., Helen Caswell, Perry Moore, Matthew A. Lambon Ralph, & Paul Hoffman. (2018). Revealing the Dynamic Modulations That Underpin a Resilient Neural Network for Semantic Cognition: An fMRI Investigation in Patients With Anterior Temporal Lobe Resection. Cerebral Cortex. 28(8). 3004–3016. 27 indexed citations
7.
Rice, Grace E., Helen Caswell, Perry Moore, Paul Hoffman, & Matthew A. Lambon Ralph. (2018). The Roles of Left Versus Right Anterior Temporal Lobes in Semantic Memory: A Neuropsychological Comparison of Postsurgical Temporal Lobe Epilepsy Patients. Cerebral Cortex. 28(4). 1487–1501. 79 indexed citations
8.
Hamid, Shahd, Perry Moore, Kerry Mutch, et al.. (2018). A severe, relapsing case of myelin oligodendrocyte glycoprotein IgG-associated CNS inflammation. Neurology Clinical Practice. 8(1). 74–76. 1 indexed citations
9.
Moore, Perry, John‐James Wilson, Amy C. Cook, et al.. (2017). PO155 Comparison of cognitive functioning between matched samples of aqp-4 antibody positive and mog antibody nmo patients with healthy controls. Journal of Neurology Neurosurgery & Psychiatry. 88(Suppl 1). A54.1–A54.
10.
Moore, Perry, et al.. (2017). Psychological interventions for persisting postconcussion symptoms following traumatic brain injury. Cochrane Database of Systematic Reviews. 4 indexed citations
11.
Mutch, Kerry, Abigail Methley, Shahd Hamid, Perry Moore, & Anu Jacob. (2016). If they are OK, we are OK: the experience of partners living with neuromyelitis optica. Disability and Rehabilitation. 39(13). 1279–1286. 6 indexed citations
12.
McIvor, K & Perry Moore. (2016). Spontaneous recovery of memory functions in an untreated case of anti NMDAR encephalitis – a reason to maintain hope. The Clinical Neuropsychologist. 31(1). 289–300. 5 indexed citations
13.
Moore, Perry, Abigail Methley, Kerry Mutch, et al.. (2015). Cognitive and psychiatric comorbidities in neuromyelitis optica. Journal of the Neurological Sciences. 360. 4–9. 57 indexed citations
14.
Methley, Abigail, Kerry Mutch, Perry Moore, & Anu Jacob. (2015). Development of a patient‐centred conceptual framework of health‐related quality of life in neuromyelitis optica: a qualitative study. Health Expectations. 20(1). 47–58. 13 indexed citations
15.
Harding, Katharine, Mark Wardle, Perry Moore, et al.. (2014). Modelling the natural history of primary progressive multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 86(1). 13–19. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026